Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular analysis of transitional cell carcinoma using cDNA microarray.

Orna Mor1, Ofer Nativ, Avi Stein

  • 1QBI Enterprises Ltd, PO Box 4071, Nes Ziona 70400, Israel. morna@qbi.co.il

Oncogene
|October 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In planta genome editing in citrus facilitated by co-expression of CRISPR/Cas and developmental regulators.

The Plant journal : for cell and molecular biology·2025
Same author

Author Correction: Multiplexed, image-based pooled screens in primary cells and tissues with PerturbView.

Nature biotechnology·2025
Same author

Author Correction: Heterochronic parabiosis reprograms the mouse brain transcriptome by shifting aging signatures in multiple cell types.

Nature aging·2025
Same author

A 2OGD multi-gene cluster encompasses functional and tissue specificity that direct furanocoumarin and pyranocoumarin biosynthesis in citrus.

The New phytologist·2025
Same author

How AI agents will change cancer research and oncology.

Nature cancer·2024
Same author

How to build the virtual cell with artificial intelligence: Priorities and opportunities.

Cell·2024
Same journal

SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma.

Oncogene·2026
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
See all related articles

Researchers identified 29 genes significantly altered in transitional cell carcinoma (TCC) compared to normal tissue. These gene expression profiles offer potential molecular tools for early TCC diagnosis and personalized treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Transitional cell carcinoma (TCC) is a rising cancer in men, with current noninvasive diagnostic tests lacking full clinical acceptance.
  • Gene expression profiling offers a promising avenue for discovering novel molecular markers for early cancer detection and patient management.

Purpose of the Study:

  • To employ gene expression profiling for the molecular analysis of TCC.
  • To identify novel molecular markers for early diagnosis and classification of TCC.
  • To differentiate between normal urothelium, noninvasive TCC, and invasive TCC.

Main Methods:

  • Construction of a TCC-derived cDNA microarray.
  • Hybridization of the microarray with probes from normal urothelium and TCC tissues.

Related Experiment Videos

  • Application of hierarchical clustering and principal components analysis for gene expression data analysis.
  • Main Results:

    • Hierarchical clustering clearly separated normal urothelium from TCC samples.
    • Identified 29 genes significantly induced in noninvasive TCC compared to normal urothelium (t-test, P<10(-5)).
    • Principal components analysis revealed distinct gene expression profiles for noninvasive and invasive TCC subsets, providing molecular fingerprints.

    Conclusions:

    • The identified genes, involved in cellular functions, tumorigenesis, and apoptosis, hold potential as molecular tools for noninvasive TCC diagnosis.
    • Gene expression profiling provides molecular fingerprints that enhance information beyond classical staging and grading for TCC.
    • This approach facilitates tumor classification, aiding in diagnosis, prognosis, and treatment selection for TCC.